Both the TGIF1 and FBXO11 loci are thought to be involved in TGF-β signalling, which implies that TGF-β may be critical in the transition from acute to chronic middle ear inflammation, and could be a future target for molecular therapies. The gene discussed is TGFB1; the disease is otitis media.